Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells | MicrobiomeTrials← Back to trialsNCT07610538
Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-03-31Est. Completion: 2028-11-01
Enrollment target: 24 participants Locations- Royal Papworth Hospital NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom
- Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom
Other microbiome trials you might be interested in
Chronic Venous Insufficiency, CVI
This is a prospective, single-arm, pre-post interventional study designed to evaluate the feasibility, safety, and impac…
Bydgoszcz, PolandCompleted May 10, 2028
CoronaryCoronary Artery Disease
The CAPRA-EVO trial is a single-center, randomized, open-label study with blinded endpoint assessment comparing early ev…
Chengdu, ChinaEst. completion Dec 31, 2028
Recruiting
Chronic Coronary SyndromeMicroplasticsNanoplasticsCoronary Artery DiseaseCoronary PlaqueComputed TomographyPollution Exposure
The CCS-plastics is an investigator-initiated, prospective, multicenter study of patients undergoing coronary CT angiogr…
Caserta, ItalyEst. completion Dec 31, 2026